Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2012; 18(12): 1339-1347
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1339
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1339
Table 3 Treatment and sustained virological response rates vs socio-economic problems and concomitant diseases
Characteristics | Treatment rate % | SVR % | n |
Drug abuse absent and employed without psychiatric disease or HIV co-infection | 58.2 | 52.7 | 4382 |
Drug abuse absent and employed without psychiatric disease | 58.2 | 52.4 | 4560 |
Drug abuse absent and employed | 57.1 | 52.6 | 4929 |
Drug abuse absent | 49.2 | 49.6 | 10 839 |
Drug abuse present | 32.0 | 49.9 | 3160 |
Drug abuse present and unemployed | 29.1 | 51.6 | 2203 |
Drug abuse present and unemployed with psychiatric disease | 25.1 | 50.8 | 470 |
Drug abuse present and employed with psychiatric disease and HIV co-infection | 7.1 | 0.0 | 56 |
- Citation: Niederau C, Hüppe D, Zehnter E, Möller B, Heyne R, Christensen S, Pfaff R, Theilmeier A, Alshuth U, Mauss S. Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice. World J Gastroenterol 2012; 18(12): 1339-1347
- URL: https://www.wjgnet.com/1007-9327/full/v18/i12/1339.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i12.1339